Oct 28, 2026 8:31am EDT HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026
Oct 26, 2026 8:31am EDT HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
Oct 21, 2026 8:31am EDT HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
Oct 15, 2026 8:31am EDT HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
Oct 05, 2026 8:31am EDT HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
Jul 30, 2026 7:00am EDT HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
Jul 14, 2026 7:00am EDT HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
Jun 30, 2026 7:00am EDT HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule